What seals inflammation in acute coronary syndromes?

International Journal of Cardiology

Volumn 135, Issue 1, 2009, Pages 108-

  Wainstein, Marco V ^a   Ribeiro, Jorge P ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acute coronary syndromes; CD40L; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND; ENDOTHELIN 1; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR INFLAMMATION; CORONARY ARTERY DISEASE; CORONARY STENT; ENDOTHELIAL DYSFUNCTION; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL;

EID: 67349277677     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.05.002     Document Type: Article

References (4)

1. Yildiz A, Yilmaz R, Demirbag R, Gur M. What seals the inflammation in acute coronary syndromes. Int J Cardiol 2008 (in press).
2. Wainstein M.V., Bento da Silva D., and Ribeiro J.P. Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes. Int J Cardiol (Oct 3 2007) [Electronic publication ahead of print]
3. Aukrust P., Muller F., Ueland T., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100 (1999) 614-620
4. Wainstein M.V., Gonçalves S.C., Zago A.J., et al. Plasma endothelin-1 levels after coronary stenting in humans. Am J Cardiol 92 (2003) 1211-1214